Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients

Kidney International

Volumn 62, Issue 5, 2002, Pages 1884-1890

  Mallamaci, Francesca ^a,b,c   Zoccali, Carmine ^a,b,c   Parlongo, Saverio ^a,b,c   Tripepi, Giovanni ^a,b,c   Benedetto, Francesco A ^a,b,c   Cutrupi, Sebastiano ^a,b,c   Bonanno, Grazia ^a,b,c   Fatuzzo, Pasquale ^a,b,c   Rapisarda, Francesco ^a,b,c   Seminara, Giuseppe ^a,b,c   Stancanelli, Benedetta ^a,b,c   Bellanuova, Ignazio ^a,b,c   Cataliotti, Alessando ^a,b,c   Malatino, Lorenzo S ^a,b,c  

^a CNR   (Italy)

^b Morelli Hospital   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cardiovascular risk; Diagnosis; End stage renal disease; Hemodialysis; Hypertension; Left ventricular hypertrophy; Uremia

Indexed keywords

TROPONIN T;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 18644362743     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00641.x     Document Type: Article

References (28)

1. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10:1606-1615, 1999
2. Zoccali C, Mallamaci F, Benedetto FA, et al: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12:1508-1515, 2001
3. Mallamaci F, Zoccali C, Tripepi G, et al: Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59:1559-1566, 2001
4. Ooi DS, Zimmerman D, Graham J, et al: Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem 47:412-417, 2001
5. Dierkes J, Domrose U, Westphal S, et al: Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102:1964-1969, 2000
6. Yeun JY, Kaysen GA: C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens 9:621-630, 2000
7. Deegan PB, Lafferty ME, Blumsohn A, et al: Prognostic value of troponin T in hemodialysis patients is independent of comorbidity. Kidney Int 60:2399-2405, 2001
8. Kanna M, Nonogi H, Sumida H, et al: Usefulness of serum troponin T levels on day three or four in predicting survival after acute myocardial infarction. Am J Cardiol 87:294-297, 2001
9. Heeschen C, Hamm CW, Bruemmer J, et al: Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 35:1535-1542, 2000
10. Musso P, Cox I, Vidano E, et al: Cardiac troponin elevations in chronic renal failure: Prevalence and clinical significance. Clin Biochem 32:125-130, 1999
11. Mockel M, Schindler R, Knorr L, et al: Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: A 9-month outcome analysis. Nephrol Dial Transplant 14:1489-1495, 1999
12. Iliou MC, Fumeron C, Benoit MO, et al: Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant 16:1452-1458, 2001
13. Anderson PA, Malouf NN, Oakeley AE, et al: Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res 69:1226-1233, 1991
14. Setsuta K, Seino Y, Takahashi N, et al: Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 84:608-611, 1999
15. Sato Y, Yamada T, Taniguchi R, et al: Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103:369-374, 2001
16. Del Carlo CH, O'Connor CM: Cardiac troponins in congestive heart failure. Am Heart J 138:646-653, 1999
17. Missov E, Mair J: A novel biochemical approach to congestive heart failure: Cardiac troponin. Am Heart J 138:95-99, 1999
18. Siciliano M, Mettimano M, Dondolini-Poli A, et al: Troponin I serum concentration: A new marker of left ventricular hypertrophy in patients with essential hypertension. Ital Heart J 1:532-535, 2000
19. Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995
20. Fermo I, Arcelloni C, Mazzola G, et al: High-performance liquid chromatographic method for measuring total plasma homocysteine levels. J Chromatogr B Biomed Sci Appl 719:31-36, 1998
21. De Simone G, Daniels SR, Devereux RB, et al: Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251-1260, 1992
22. Zoccali C, Benedetto FA, Mallamaci F, et al: The prognostic impact of the indexations of left ventricular mass in dialysis patients. J Am Soc Nephrol 12:2768-2774, 2001
23. Zoccali C, Mallamaci F, Tripepi G, et al: Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens 17:1751-1758, 1999
24. Altman DG: Two further ways for looking at diagnostic tests: The likelihood ratio and the ROC curve, in Practical Statistics for Medical Research, edited by Altman DG, London, Chapman & Hall, 1991, pp 416-418
25. Levey AS, Beto JA, Coronado BE, et al: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32:853-906, 1998
26. Kaye D, Pimental D, Prasad S, et al: Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest 97:281-291, 1996
27. Rostand SG, Brunzell JD, Cannon RO, et al: Cardiovascular complications in renal failure. J Am Soc Nephrol 2:1053-1062,1991
28. Roppolo LP, Fitzgerald R, Dillow J, et al: A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: A pilot study. J Am Coll Cardiol 34:448-454, 1999